Explore

Trendline Trendline
DexCom Faces Securities Fraud Class Action Over Alleged Unauthorized Device Changes

DexCom Faces Securities Fraud Class Action Over Alleged Unauthorized Device Changes

DexCom Faces Securities Fraud Class Action Over Alleged Unauthorized Device Changes
Trendline Trendline
Stride, Inc. Faces Securities Fraud Lawsuit Amid Stock Drop

Stride, Inc. Faces Securities Fraud Lawsuit Amid Stock Drop

Stride, Inc. Faces Securities Fraud Lawsuit Amid Stock Drop
Trendline Trendline
Firefly Aerospace Faces Class Action Lawsuit Over Alleged Misleading Statements

Firefly Aerospace Faces Class Action Lawsuit Over Alleged Misleading Statements

Firefly Aerospace Faces Class Action Lawsuit Over Alleged Misleading Statements
Trendline Trendline
Faruqi Faruqi, LLP Investigates aTyr Pharma for Alleged Securities Law Violations

Faruqi Faruqi, LLP Investigates aTyr Pharma for Alleged Securities Law Violations

Faruqi Faruqi, LLP Investigates aTyr Pharma for Alleged Securities Law Violations
Trendline Trendline
Freeport-McMoRan Inc. Faces Securities Fraud Lawsuit After Stock Decline

Freeport-McMoRan Inc. Faces Securities Fraud Lawsuit After Stock Decline

Freeport-McMoRan Inc. Faces Securities Fraud Lawsuit After Stock Decline
Trendline Trendline
Faruqi Faruqi Reminds Marex Investors of Class Action Lawsuit Deadline

Faruqi Faruqi Reminds Marex Investors of Class Action Lawsuit Deadline

Faruqi Faruqi Reminds Marex Investors of Class Action Lawsuit Deadline
Trendline Trendline
Kessler Topaz Meltzer Check, LLP Investigates uniQure N.V. Following FDA Setback

Kessler Topaz Meltzer Check, LLP Investigates uniQure N.V. Following FDA Setback

Kessler Topaz Meltzer Check, LLP Investigates uniQure N.V. Following FDA Setback
Trendline Trendline
uniQure Faces Investor Scrutiny Following FDA Setback on Gene Therapy

uniQure Faces Investor Scrutiny Following FDA Setback on Gene Therapy

uniQure Faces Investor Scrutiny Following FDA Setback on Gene Therapy
Trendline Trendline
Stride Faces Class Action Lawsuit Over Alleged Securities Violations

Stride Faces Class Action Lawsuit Over Alleged Securities Violations

Stride Faces Class Action Lawsuit Over Alleged Securities Violations
Trendline Trendline
Forescout Technologies Settles Securities Fraud Claims for $45 Million

Forescout Technologies Settles Securities Fraud Claims for $45 Million

Forescout Technologies Settles Securities Fraud Claims for $45 Million
Trendline Trendline
Stride, Inc. Faces Securities Fraud Lawsuit Following Significant Stock Drop

Stride, Inc. Faces Securities Fraud Lawsuit Following Significant Stock Drop

Stride, Inc. Faces Securities Fraud Lawsuit Following Significant Stock Drop
Trendline Trendline
Faruqi Faruqi Alerts Blue Owl Capital Investors on Class Action Lawsuit Deadline

Faruqi Faruqi Alerts Blue Owl Capital Investors on Class Action Lawsuit Deadline

Faruqi Faruqi Alerts Blue Owl Capital Investors on Class Action Lawsuit Deadline